Prevention and Treatment of Thromboembolism in Patients with Inflammatory Bowel Disease.
10.4166/kjg.2015.65.3.151
- Author:
Jae Jun PARK
1
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. jaejpark@yuhs.ac
- Publication Type:Review
- Keywords:
Inflammatory bowel disease;
Venous thromboembolism;
Prevention;
Treatment;
Anticoagulation
- MeSH:
Anticoagulants/*therapeutic use;
Heparin, Low-Molecular-Weight/therapeutic use;
Humans;
Inflammatory Bowel Diseases/complications/*diagnosis;
Platelet Aggregation Inhibitors/therapeutic use;
Risk Factors;
Venous Thromboembolism/*drug therapy/etiology/prevention & control
- From:The Korean Journal of Gastroenterology
2015;65(3):151-158
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Although inflammatory bowel disease (IBD) is a chronic disorder that mainly affects the gastrointestinal tract, extraintestinal complications can occur in IBD patients. Among many extraintestinal complications, venous thromboembolism (VTE) is particularly a feared complication due to its significant morbidity and mortality. IBD patients have about 2 to 3 fold higher risk of developing VTE compared with the general population, and the current management guidelines for IBD patients propose recommendations for the prevention of VTE. This review aims to summarize clinical characteristics of VTE in IBD patients and to outline strategies for preventing and treating VTE in these patients.
